Prospects for ensuring acceptance of ES cell-derived tissues
- PMID: 20963944
- Bookshelf ID: NBK47455
Prospects for ensuring acceptance of ES cell-derived tissues
Excerpt
ES cell-derived tissues exhibit a degree of immune privilege and can be naturally accepted across weak histocompatibility mismatches without any added immunosuppression. This is, in part, due to the lack of donor dendritic cells (DC) which would directly stimulate host T cell responses. In addition to this, there can be recruitment and/or induction of Treg which suppress immune attack against the tissue. This might explain why ES cell-derived tissues are so amenable to tolerance induction protocols, such as co-receptor blockade with monoclonal antibodies, when compared to skin grafts. Co-receptor blockade also appears to enhance the protective effect of regulatory T-cells
Copyright: © 2010 Kathy O. Lui, Paul J. Fairchild and Herman Waldmann.
Sections
- Introduction
- Central tolerance
- esDC as a negative vaccine against graft rejection
- Immunological privilege of ES cell-derived tissues
- Proposed mechanisms of natural privilege operating in ES cell-derived tissues
- Induction of donor-specific tolerance for ES cell-derived tissues
- Conclusion
- Acknowledgements
- References
References
-
- Aaltonen J, Björses P, Perheentupa J, Horelli−Kuitunen N, Palotie A, Peltonen L., Lee Y.S, Francis F, Henning S, Thiel C, Leharach H, Yaspo M-L. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet. 1997;17:399–403. doi: 10.1038/ng1297-399. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources